ALBO
Albireo Pharma Inc

2,605
Loading...
Loading...
Albireo Pharma, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of novel bile acid modulators for the treatment of orphan pediatric liver diseases and gastrointestinal disorders. Its pipeline products include Odevixibat, A3384, and Elobixibat. The company was founded by Jan Peter Mattsson and Per-Göran Gillberg on December 8, 2003 and is headquartered in Boston, MA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A

Frequently Asked Questions

What is Market Cap of Albireo Pharma Inc?
What is the 52-week high for Albireo Pharma Inc?
What is the 52-week low for Albireo Pharma Inc?
What is Albireo Pharma Inc stock price today?
What was Albireo Pharma Inc stock price yesterday?
What is the PE ratio of Albireo Pharma Inc?
What is the Price-to-Book ratio of Albireo Pharma Inc?
What is the 50-day moving average of Albireo Pharma Inc?

Latest ALBO News

View
No ALBO news at the moment.

Advertisement. Remove ads.

Advertisement. Remove ads.